C-Reactive protein on admission and the success of thrombolytic therapy with streptokinase: is there any relation?

Author： Amasyali B.   Kose S.   Kilic A.   Iyisoy A.   Barcin C.   Kursaklioglu H.   Barindik N.   Tokgoz S.   Isik E.   Demirtas E.  

Publisher： Elsevier

ISSN： 0167-5273

Source： International Journal of Cardiology, Vol.92, Iss.1, 2003-11, pp. : 27-33

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Streptokinase—the drug of choice for thrombolytic therapy

By Kunamneni Adinarayana   Abdelghani Thaer   Ellaiah Poluri  

Journal of Thrombosis and Thrombolysis, Vol. 23, Iss. 1, 2007-02 ,pp. : 9-23

Springer Publishing Company

Access to resources Recommend Favorite

Streptokinase-A Drug for Thrombolytic Therapy: A Patent Review

By  

Recent Patents on Cardiovascular Drug Discovery, Vol. 9, Iss. 2, 2014-12 ,pp. : 106-121

Bentham Science Publishers

Access to resources Recommend Favorite

Admission C-reactive protein levels and 30-day mortality in patients with acute myocardial infarction

By Suleiman M.   Aronson D.   Reisner S.A.   Kapeliovich M.R.   Markiewicz W.   Levy Y.   Hammerman H.  

The American Journal of Medicine, Vol. 115, Iss. 9, 2003-12 ,pp. : 695-701

Elsevier

Access to resources Recommend Favorite

C-reactive protein: history and revival

By Ablij H.C.   Meinders A.E.  

European Journal of Internal Medicine, Vol. 13, Iss. 7, 2002-10 ,pp. : 412-422

Elsevier

Access to resources Recommend Favorite

C-Reactive Protein and Atherosclerosis: An Update

By  

Vascular Disease Prevention, Vol. 5, Iss. 3, 2008-08 ,pp. : 178-182

Bentham Science Publishers

Access to resources Recommend Favorite